WE THINK SO !!
Dnaprint (DNAP) is an emerging biotech company and is trading under $1 !!!
1) CEO (Dr. Tony Frudakis) Lead scientist for Corixa starts his own company a
few months ago
2) Company is formed by a reverse merger of a pinksheet company
3) DNAP has already completed the accounting to get off the pinksheets and
should be listed on the OTCBB soon.
4) Dr. Frudakis was responsible for a patent that sold for $54,000,000 to
Smith Kline Beecham while he was at Corixa.
5) Corixa's stock has gone from 14 Cents a few years ago to 50 Dollars today.
6) According to the Barron's article (9/25/00 pg 52), Dnaprint is in the late stages
of forming
strategic alliances with major companies.
MAJOR WEB PAGES RELATED TO DNAP
dnap
http://www.dnaprint.com/
orchid biosciences inc
http://www.orchidbio.com/
INVEST IN DNAP
email for free investment package= [EMAIL PROTECTED]
or call 1-877-362-3453(toll free)
investment club web page=http://clubs.yahoo.com/clubs/dnaprintgenomicsinvestors
investors report=
http://www.companyreporter.com/index.php?u=companies.php
great dnap investor links:
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=22034
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=23118
http://cbs.marketwatch.com/news/current/molinski.htx?source=htx/http2_mw =invest in
biotech
http://www.loonycat.com/Genomics.htm =the human genome investors portal
clearstation rates danp
http://www.clearstation.com/cgi-bin/details?Event=peek&Symbol=DNAP&Refer=http://www.purepennies.com/
purepenny&3bagger rate dnap
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132938
Pennystockprofits assess dnap
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=15730
tipreporter rates dnap http://www.tipreporter.com/search.php?search=dnap
dnap on stocktribes hotlist for 21 weeks
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=24335
analysts tips and reports on dnap
http://www.tipreporter.com/search.php?search=dnap
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=15730
why is dnap unique in the bio tech sector??
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=22654
NEWSLINKS GENERAL FOR DNAP
dnap company news
http://www.bell2bell.newsalert.com/bin/digest?Symbol=DNAP&; =bell2bell news
http://quicken.excite.com/investments/quotes/?s=DNAP&t=0 =excite news
http://biz.yahoo.com/n/D/DNAP.html =yahoo news
dnap in barrons http://www.sockthestocks.com/profiles/dnapbarrons.htm
bioinform news service
http://www.bioinform.com/
online journal of bioinformatics
http://www.cpb.uokhsc.edu/ojvr/xmlpaper.html#Sites
UPCOMING EVENTS RELATED TO DNAP
bio partnering Europe- London England-16-17 oct 2000
http://www.biopartnering.com/bpe/index.html
structural genomics conference-yokohama,japan,2-5nov2000
http://icsg2000.riken.go.jp/
TECHNICAL SITES RELATED TO DNAP
dnap patents
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=21559
dnap is about pharmacogentics
http://www.nigms.nih.gov/funding/medforyou.html
stem cell research
http://www.stemcellresearchnews.com/index.html
personalized medicine no longer science fiction
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=25033
safe drugs that fit like a glove
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=11203
NEW STAFF ARRIVING AT DNAP SARASOTA
dr. ramin mirashemi, a new dnap addition—check this track record!!!!!!!!!!!!
http://www.google.com/search?q=Ramin+Mirhashemi&hl=en&lr=&safe=off&start=0&sa=N
dr.jose arena joins dnap scientific advisory board 03 oct 2000
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=23532
scientific advisory board makeup
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=24575
DNAP COMPARED TO ITS TECHNICAL EQUALS, AND RIVALS:
genomica(gnom)nasdq-ipo29sept00($19)now$22
http://www.bell2bell.newsalert.com/bin/story?StoryId=CoDqtWbWbtKvgmda1&FQ=genomica&HdlFmt=simple&Title=Headlines%20for%3A%20genomica
informax(inunx)nasdq-ipo-03oct00($16)now$23
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=23532
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=23552
incite genomics(incy)nasdq $37
http://quicken.excite.com/investments/news/?symbol=INCY
genentech(dna)($172)-2for1split 5 oct00-263million share float---dnap float = 269
million
http://www.bell2bell.newsalert.com/bin/digest?Symbol=DNA&;
DNAP IN EUROPE
http://www.8ung.at/zockstocks
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=21485
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=24168
WHERE IS DNAP LOCATED—HOW DO YOU GET THERE?
great air fare rates round trip to sarasota
http://leisure.travelocity.com/RealDeals/Details/0,2941,TRAVELOCITY_AIR_449,00.html
dnaps new upscale digs in swinging sarasota, fla
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=DNAP&read=21059
motel shopper link for sunny sarasota area
http://www.roomsaver.com/roomsaver/city/index.html?state=FL&city=Sarasota
location map of coconut ave digs
http://maps.yahoo.com/py/maps.py?BFCat=&Pyt=Tmap&newFL=Use+Address+Below&addr=900+COCONUT+AVE&csz=SARASOTA%2CFLORIDA%2C+34234&country=us&Get%A0Map=Get+Map
avis rent a car sarasota
http://www.avis.com/cgi-bin/maps_and_directions/driving_maps/us_locations/mqinterconnect
INTELLIGENT ADVICE OR BIASED ROT?KNOW THE DIFFERENCE OR HOW TO USE THESE MESSAGE
BOARDS
email suspected lying-sham efforts,etc to your federal govt(it,s called the sec) at
[EMAIL PROTECTED]
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132869
get the mob out of microcaps
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132789
crush naked shorting –stop being screwed without even knowing it—read me
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132581
suspicious sounding codswallop?? ask them to take the universal basher quiz!!!!
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132816
dnap has unusually good promise—accounting for the sad fact that were in “basher
heaven”-read me
http://www.ragingbull.altavista.com/mboard/boards.cgi?board=PCBM&read=132818
sec offers tips on how to avoid scams on the internet—good article
http://www.sec.gov/consumer/cyberfr.htm
CONTENTS
1.BACKGROUND
2.FOUNDERS
3.PRODUCTS&SERVICES
1.BACKGROUND
DNAPrint genomics is a young e-biotech company based in southwest Florida. We are
developing an informatics platform system that will provide dynamic solutions for
disease gene discovery, genetic predisposition and genetic analysis testing. Our work
has real-life application to the germinating field of Personalized Medicine and will
help lay the foundation for a brand-new area of medical research called Phenomics.
The PhenomeSM platform system that we are developing will help identify an individual
predisposed to develop cancer before the onset of illness so that lifestyles can be
altered and/or preventative measures taken. It will be used to identify individuals
who are incompatible with certain drug treatments before the drugs are prescribed and
damage is done. It will be used to tease out important genetic determinants associated
with complex genetic diseases, so that drugs can be developed to target these genes.
Our aim is ambitious. By partnering our platform with biotech/pharma, we will
participate in the downstream profits generated from pharmaceutical products our
platform has enabled. By marketing our platform directly to the public, we intend to
make comprehensive genotype screening solutions accessible to people all over the
world via the internet. Our system will enable a more holistic approach to using
genomics information to improve peoples lives.
The patient of the future will have more information and power than ever imagined. The
human genome project, the internet and recent technological advancements all
contribute to make this possible, and we intend to take advantage of these synergies
to become the primary conduit for the generation and distribution of personalized
genetic information.
The Market
Pharmacogenomics is currently a 1 billion dollar industry and is projected to be a 10
billion dollar industry by the end of 2003. Several billions of dollars have been
spent on the human genome project so far, and an equal amount will likely be spent
trying to understand what all of the genomics information means (i.e. bioinformatics,
proteomics and phenomics). Genomics is a multi billion dollar industry world-wide and
the market for personalized medicine is expected to exceed $25 billion dollars by
2010. Recently congress has approved a $2.3 billion increase in NIH funding to a total
of $18 billion dollars for the year 2000.
2.FOUNDERS
Tony Frudakis, Ph.D.([EMAIL PROTECTED])
Chief Executive Officer, President and Laboratory Director. Dr. Tony Frudakis is a Phi
Beta Kappa, Magna Cumme Laude graduate of the University of California system. He
received his doctorate degree in molecular and cell biology from the University of
California Berkeley and has 14 total years of experience as a molecular biologist. Dr.
Frudakis' technical experience encompass a range of areas within biology, including
the molecular biology of eukaryotic transcriptional regulation, the creation and study
of transgenic animals, the development of novel nucleic acid isolation techniques and
gene discovery protocols, bioinformatics processing and anatomical gene expression
profiling. At Corixa Corporation in Seattle, WA he developed several new techniques
for RNA fingerprinting, managed and executed high-throughput gene discovery programs
for various cancers and was instrumental in the companies early success in attracting
R and D partners. Founding GAFF biologic in 1998, Dr. Fru!
!
!
!
dakis established a good reputation for high quality DNA sequencing and library
construction/screening services, until its evolution into the DNAPrint Genomics that
exists today. In all, his work has resulted in a patent portfolio for over 350 unique
genes and 2 products
George Frudakis([EMAIL PROTECTED])
Vice President of Business Affairs. George Frudakis has vast experience with start-up
company development. He started and developed a successful multi-component company
called GAFF group, which today enjoys over 15 million dollars annually in revenue.
During his life’s work as an entrepreneur and businessman, George has learned how to
run and successfully manage the financial and operational aspects of both small and
large companies alike. He is a graduate from the California State University at Long
Beach in California.
Myung Ho Kim, Ph.D. Mathematics([EMAIL PROTECTED])
Director of Informatics and Lead Mathemetician. Myung recieved his Ph.D. in
Mathematics from the University of Michigan in Ann Arbor in 1988 and M.S. in
Mathematics from The Ohio State University in Columbus Ohio. Most recently, Myung
worked on the Ant World Server project supported by DARPA (Defense Advanced Research
Progect Agency) and implemented Kolmogorov-Smirnov tests, linear/nonlinear regression,
nonparametric analysis and modeling to a TREC 6 (Text Retrieval Conference) project
using SAS, C/C++ and Perl languages. Prior to this, Myung simulated mathematical
modeling for breast tumors and implemented/developed various image processing
algorithms. He has served as an Honorary research Fellow in the Department of
Mathematics and Information Science at the University of Auckland, New Zealand and a
Visiting Research Scholor in the Department of Mathematics at the University of
California at Santa Cruz in California. Prior to coming to the United States, Myung
held the posit!
!
!
!
ion of Assistant Professor in the Department of Mathematics at Sungkyunkwan University
in Soel Korea.
Venkateswarlu Kondragunta, Ph.D. ([EMAIL PROTECTED])
Director of Biostatistics. Dr. Kondragunta obtained his Ph.D. in Statistics from the
University of Madras, Madras, India. He most recently served as a Postdoctoral Fellow
at the Schoolof Public Health, University of Texas, Houston, TX under the tutelage of
Dr. Ranajit Chakraborty, one of the most famous and accomplished genetic
mathematicians in the world. His research interests include variance components,
linear regression models, general linear models, design and analysis, discriminant
analysis, principal component analysis and statistical genetics. He has taught courses
in Variance Components, Design and Analysis of Experiments and Linear Regression
Models and Probability Theory at Concordia University in Montreal, Canada. Dr.
Kondragunta is an accomplished programmer and has amassed considerable experience with
implementing statistical genetic ideas into C++, S-plus, FORTRAN (7 years experience)
and JAVA code. His most recent work used the REG, ANOVA, GLM, VARCOMP, CANDIS!
!
!
!
C, CLUSTER, DISCRIM, FACTOR, PRINCOMP and LOGISTIC tools in the SAS computing
environment on real and simulated data sets.
A partial list of publications for Dr. Kondragunta include:
Chaubey, Y.P. and K.Venkateswarlu. A numerical study of some robust estimators of
variance components in one-way model. International Indian Statistical Association
Conference proceedings, October 10-11, 1998, McMaster University, Hamilton, Canada.
Venkateswarlu, K. K.N.Ponnuswamy, and M.R.Srinivasan. Estimation of variance
components based on diallel model. Mathematical Biosciences, V-150, 105-112.
Venkateswarlu, K, and K.N.Ponnuswamy. Estimation of variance components based on
bio-model of diallel crosses (balanced). Communications in Statistics (Theory &
Methods), Vol-27, 139-152.
Venkateswarlu, K. Estimation of variance components based on diallel model involving
maternal and maternal interaction effects. Biometrical Journal, Vol-39, 287-295.
3.PRODUCTS&SERVICES
see dnap web page for a complete description of products & services
http://www.dnaprint.com/
SNiPdocTM
High-throughput SNP profiling-To help us with our bottom line, we provide contract SNP
profiling services to the drug development community. We call this service our
SNiPdocTM service, and it is targeted towards pharmaceutical companies. Many
pharmaceutical companies are seeking to enter into the field of Pharmacogenomics. This
new field of study could have a dramatic impact on overall health care costs in the
future. Furthermore, by having access to pharmacogenomics data, pharmaceutical
companies can focus their clinical trials on segments of the population that are
genetically receptive to the treatment. Experimental drugs can be targeted to
individuals of a particular genotype, and genetic variations shown to underlie a
poor-response to a trial drug could be used as a basis for eliminating the
non-responding segment of the trial population from the study. In this way,
pharmaceutical companies can reduce drug trial failures and the costs associated with
them. Contracting thi!
!
!
!
s work out to service providers is a viable option for many smaller pharmaceutical
companies who do not have the volume of work necessary to justify the price of the
equipment and expertise. At DNAPrint Genomics, we offer multiple patient – multiple
SNP sampling matricies designed on a custom, semi-custom or predefined basis. We can
use our proprietary PhenomixM databases of medically relevant SNPs (numbering in the
thousands of SNPs at present), or design chips for your application de-novo. We will
work with your scientists to develop the experiments from beginning to end, that suit
your needs, and we can handle your project from blood/tissue or DNA starting points.
Data handling will be customized for each client; data can be deposited in our secure
SNP relational databases system offering you the option of accessing your data over
the internet. Alternatively, we can burn and hand-delivered CDs to
Raging Bull Advertisements Looking for ORACLE E-BUSINESS SOLUTIONS?
See Blasters and Disasters, Free! M4Logic
All Your Accounts in One Place -- Free & Easy!
